NBACC

Appili Therapeutics Appoints Dr. Gary Nabors as Chief Development Officer

Retrieved on: 
Monday, April 3, 2023
Medical Supplies, Health, Infectious Diseases, Research, Science, Pharmaceutical, Biotechnology, Vaccine, Infection, GMP, IBT, Drug development, Therapy, U.S. Department of Commerce Office of Security, Doctor of Philosophy, Advisory Committee on Immunization Practices, Food, General Dynamics, Tularemia, Unitary state, Food and Drug Administration, Emergent, Government, National Biodefense Analysis and Countermeasures Center, Congress, Privacy Office of the U.S. Department of Homeland Security, TSX, Nabors Industries, Integration, FDA, IND, CL, Skin, NBACC, Sanofi Pasteur, Pharmaceutical industry

Appili Therapeutics Inc. (TSX: APLI; OTCQB: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced that it has appointed biopharmaceutical industry veteran Gary Nabors, Ph.D., to serve as Appili’s Chief Development Officer.

Key Points: 
  • Appili Therapeutics Inc. (TSX: APLI; OTCQB: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced that it has appointed biopharmaceutical industry veteran Gary Nabors, Ph.D., to serve as Appili’s Chief Development Officer.
  • Dr. Nabors joins Appili effective April 3, 2023, and will lead the advancement of programs through development, regulatory submission and key commercialization milestones.
  • Nabors brings an exceptional wealth of experience and established results to Appili, and he will play a critical role in advancing our programs and our business,” said Dr. Don Cilla, President and Chief Executive Officer of Appili Therapeutics.
  • He has played a central role in product development from pre-clinical stages through to Phase 3, for development of vaccines and therapeutics for pediatric, adult, and biodefense markets.

Dr. Nicholas Bergman Selected NBACC Lab Director

Retrieved on: 
Thursday, March 2, 2023
Research, Other Defense, Contracts, White House, Federal Government, Law Enforcement, Emergency Services, Technology, Defense, Security, Science, Homeland Security, Other Science, Public Policy, Government, FBI, DHS, International Fertilizer Development Center, Massachusetts Institute of Technology, National Biodefense Analysis and Countermeasures Center, Funding, NBACC, Doctor of Philosophy, DHS Science and Technology Directorate, U.S. Department of Commerce Office of Security, Lab, United States national laboratories, Partnership, Management

The Battelle National Biodefense Institute (BNBI) is proud to announce the appointment of Dr. Nicholas H. Bergman as the new Lab Director for the National Biodefense Analysis and Countermeasures Center (NBACC).

Key Points: 
  • The Battelle National Biodefense Institute (BNBI) is proud to announce the appointment of Dr. Nicholas H. Bergman as the new Lab Director for the National Biodefense Analysis and Countermeasures Center (NBACC).
  • Dr. Bergman brings a wealth of experience at NBACC and in the biodefense and biosecurity community, as well as unparalleled scientific credentials.
  • The BNBI Board is excited for the future of NBACC and the partnership with the DHS, FBI, Dr. Bergman, NBACC leadership team, and NBACC staff."
  • Prior to taking on the acting position he was the Associate Lab Director for NBACC’s National Bioforensic Analysis Center.

Dr. Korch to Retire as NBACC Lab Director

Retrieved on: 
Friday, August 26, 2022
Defense, Other Science, Research, Other Defense, Science, Contracts, National Biodefense Analysis and Countermeasures Center, DHS Science and Technology Directorate, COVID-19, Workforce, Federally funded research and development centers, Science, Human services, Technology, Program, Education Development Center, Fort Detrick, State bureau of investigation, Department, Multimedia, Retirement, United States Secretary of Homeland Security, NBACC, Assistant, SARS, Federal Bureau of Investigation, Management, United States Army

Today Dr. George W. Korch announced his retirement at the end of September, 2022 as Director of the National Biodefense Analysis and Countermeasures Center (NBACC) and President of the Battelle National Biodefense Institute (BNBI).

Key Points: 
  • Today Dr. George W. Korch announced his retirement at the end of September, 2022 as Director of the National Biodefense Analysis and Countermeasures Center (NBACC) and President of the Battelle National Biodefense Institute (BNBI).
  • During his tenure, NBACC personnel and program achieved national recognition for their timely and important studies regarding the SARS CoV-2 virus biological response and viability.
  • Dr. Nicholas Bergman will take over as acting BNBI President and NBACC Laboratory Director, while BNBI conducts a comprehensive and inclusive national search for its next President and Lab Director.
  • NBACC, a Federally Funded Research and Development Center, is operated and managed by BNBI for the DHS Science and Technology Directorate.